Commentary Open Access
Clinical Considerations for Concussion Management in Adaptive Athletes
Siyuan Liu1, Rehaan Muqeet2, Zoe Uihlein3, Beth Weinman4, Michael Uihlein5, Alexander Senk6, Khazi Muqeet7, Kenneth Lee8,*
- 1MS2, Medical College of Wisconsin, Milwaukee, WI, USA
- 2Research Assistant/Volunteer, Wisconsin Adaptive Sports Association, Brookfield, WI, USA
- 3Bachelor of Science, Honors College, University of Wisconsin, Madison, WI, USA
- 4Assistant Professor, Department of Orthopedics, Medical College of Wisconsin, Milwaukee, WI, USA
- 5Assistant Professor, Department of Emergency Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
- 6Professor, Department of Rehabilitation Medicine, University of Minnesota, Minneapolis, MN, USA
- 7Assistant Professor, Department of Psychiatry, Medical College of Wisconsin, Milwaukee, WI, USA
- 8Professor, Department of Physical Medicine & Rehabilitation, Medical College of Wisconsin, Milwaukee, WI, USA
Corresponding Author
Kenneth Lee, MD, Kenneth.Lee8@va.gov
Received Date: September 25, 2025
Accepted Date: June 25, 2026
Liu S, Muqeet R, Uihlein Z, Weinman B, Uihlein M, Senk A, et al. Clinical Considerations for Concussion Management in Adaptive Athletes. J Ment Health Disord. 2026;6(1):102–106.
Copyright: © 2026 Liu S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Microptofluidic Technology for Biodiagnostics of Traumatic Brain Injury: A Commentary
Traumatic brain injury (TBI) is a leading cause of death and neurological disability worldwide with millions of people sustaining and living with its long-term effects []. TBI is often categorized as mild, moderate and severe with primary injuries separated as either focal or diffuse, with the latter including contusions, intracranial hematomas and brain herniation.
Differential Fecal Microbiome Dysbiosis after Equivalent Traumatic Brain Injury in Aged Versus Young Adult Mice
Traumatic brain injury (TBI) has a bimodal age distribution with peak incidence at age 24 and age 65 with worse outcomes developing in aged populations
In the Mind of the US Olympic Athletes; Longevity Advantage and Its Relation to Nervous System Disorders and Mental Illness
In a recent study of 8124 US Olympic athletes, Antero et al. [1] found that the US Olympic athletes live 5 years longer than their general counterparts.
Commentary: Calcitonin Gene Related Peptide and Its Clinical Utility for the Treatment of Traumatic Brain Injury, Subarachnoid Hemorrhage and Associated Migraine
Calcitonin gene related peptide (CGRP) is a potent vasodilator and neurotransmitter that has been extensively studied in the context of migraine pathophysiology. Recently, studies have explored its role in the treatment of traumatic brain injury (TBI) and subarachnoid hemorrhage (SAH). Although a multitude of therapies exist for migraine, there has been little study on the management of migraine following neurologic injury.
Inulin Supplementation Mitigates Gut Dysbiosis and Brain Impairment Induced by Mild Traumatic Brain Injury during Chronic Phase
Mild traumatic brain injury (mTBI) has been shown to acutely alter the gut microbiome diversity and composition, known as dysbiosis, which can further exacerbate metabolic and vascular changes in the brain in both humans and rodents. However, it remains unknown how mTBI affects the gut microbiome in the chronic phase recovery (past one week post injury). It is also unknown if injury recovery can be improved by mitigating dysbiosis. The goal of the study is to fill the knowledge gap.